World's Best Scientists 2026 revealed!
Massimo Terzolo

Massimo Terzolo

D-Index & Metrics

Medicine

D-Index
81
Citations
26824
World Ranking
16536
National Ranking
660

Massimo Terzolo publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Massimo Terzolo sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 399 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Massimo Terzolo D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Massimo Terzolo sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Massimo Terzolo is affiliated with the University of Turin in Italy and has published extensively in the field of medicine, with a primary focus on endocrinology, diabetes, metabolism, surgery, and cancer research. Their research encompasses a broad range of topics related to adrenal and paraganglionic tumors, hormonal regulation and hypertension, pituitary gland disorders and treatments, cancer biology, adrenal hormones and disorders, glioma diagnosis and treatment, and clinical research on COVID-19.

The scientist has contributed to several recent papers, including:

  • European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors (2023, European Journal of Endocrinology)
  • Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up (2020, Annals of Oncology)
  • Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study (2020, The Lancet Diabetes & Endocrinology)
  • Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study (2022, The Lancet Diabetes & Endocrinology)
  • Adrenal Incidentalomas are Tied to Increased Risk of Diabetes: Findings from a Prospective Study (2020, The Journal of Clinical Endocrinology & Metabolism)

Frequent co-authors include Soraya Puglisi, Giuseppe Reimondo, Martin Faßnacht, Darko Kaštelan, and Anna Calabrese. This collaboration highlights a multidisciplinary approach to complex endocrine and oncological conditions.

Terzolo's work is regularly published in several key journals and venues such as:

  • Endocrine Abstracts
  • Journal of the Endocrine Society
  • European Journal of Endocrinology
  • Cancers
  • Frontiers in Endocrinology

Their main fields of study include medicine, with concentrated research in the subfields of endocrinology, diabetes and metabolism, surgery, cancer research, genetics, and neurology. Massimo Terzolo's research topics frequently address adrenal and paraganglionic tumors, hormonal regulation and hypertension, pituitary gland disorders and treatments, cancer-related hypoxia and metabolism, adrenal hormones and disorders, glioma diagnosis and treatment, and clinical studies relating to COVID-19.

Best Publications

  • Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors

    Martin Fassnacht;Wiebke Arlt;Irina Bancos;Irina Bancos;Henning Dralle

  • A Survey on Adrenal Incidentaloma in Italy

    Franco Mantero;Massimo Terzolo;Giorgio Arnaldi;Giangiacomo Osella

  • Combination Chemotherapy in Advanced Adrenocortical Carcinoma

    Martin Fassnacht;Massimo Terzolo;Bruno Allolio;Eric Baudin

  • Adjuvant mitotane treatment for adrenocortical carcinoma.

    Massimo Terzolo;Alberto Angeli;Martin Fassnacht;Fulvia Daffara

  • Prevalence of adrenal incidentaloma in a contemporary computerized tomography series

    S. Bovio;A. Cataldi;G. Reimondo;P. Sperone

  • European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors

    Martin Fassnacht;Olaf M. Dekkers;Olaf M. Dekkers;Tobias Else;Eric Baudin;Eric Baudin

  • A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology.

    Mantero F;Terzolo M;Arnaldi G;Osella G

  • Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification.

    Martin Fassnacht;Sarah Johanssen;Marcus Quinkler;Peter Bucsky

  • AME Position Statement on adrenal incidentaloma

    Massimo Terzolo;Antonio Stigliano;Iacopo Chiodini;Paola Loli

  • Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors

    Wiebke Arlt;Michael Biehl;Angela E. Taylor;Stefanie Hahner

  • Adrenal incidentaloma: a new cause of the metabolic syndrome?

    Massimo Terzolo;Anna Pia;Anna Alì;Giangiacomo Osella

  • Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial.

    Alfredo Berruti;Massimo Terzolo;Paola Sperone;Anna Pia

  • Non-functioning pituitary adenoma database : a useful resource to improve the clinical management of pituitary tumors

    Emanuele Ferrante;Monica Ferraroni;Tristana Castrignanò;Laura Menicatti

  • Clinically Guided Genetic Screening in a Large Cohort of Italian Patients with Pheochromocytomas and/or Functional or Nonfunctional Paragangliomas

    Massimo Mannelli;Maurizio Castellano;Francesca Schiavi;Sebastiano Filetti

  • Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study

    Martin Fassnacht;Alfredo Berruti;Eric Baudin;Michael J Demeure

  • Major Prognostic Role of Ki67 in Localized Adrenocortical Carcinoma After Complete Resection

    Felix Beuschlein;Jens Weigel;Wolfgang Saeger;Matthias Kroiss

  • Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†

    M. Fassnacht;G. Assie;E. Baudin;G. Eisenhofer

  • Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group.

    Angeli A;Osella G;Alì A;Terzolo M

  • Subclinical Cushing's syndrome in adrenal incidentaloma.

    M Terzolo;G Osella;A Alì;G Borretta

  • Predictors of morbidity and mortality in acromegaly: an Italian survey

    M Arosio;G Reimondo;E Malchiodi;P Berchialla

Frequent Co-Authors

Alfredo Berruti
Alfredo Berruti University of Brescia
Martin Fassnacht
Martin Fassnacht University of Würzburg
Mauro Papotti
Mauro Papotti University of Turin
Francesco Porpiglia
Francesco Porpiglia University of Turin
Felix Beuschlein
Felix Beuschlein University of Zurich
Wiebke Arlt
Wiebke Arlt University of Birmingham
Marcus Quinkler
Marcus Quinkler Charité - University Medicine Berlin
Eric Baudin
Eric Baudin Institut Gustave Roussy
Jérôme Bertherat
Jérôme Bertherat Université Paris Cité
Franco Mantero
Franco Mantero University of Padua

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens the door to a wide range of rewarding careers, both clinical and non-clinical. Many students and professionals are now seeking flexible and affordable pathways to enter or advance in healthcare through online studies.

For those looking to start or change their healthcare career, a cheapest online health science degree can provide you with foundational knowledge at a reasonable cost. Additionally, advancing into leadership is possible with a cheapest master's in healthcare administration, offering specialized management skills for healthcare settings.

Those pursuing advanced clinical roles have options as well. If you are a nurse seeking the highest level of practice, least expensive dnp programs offer online doctorates tailored to busy professionals. Pharmacists aiming to expand their expertise can benefit from pharmd online programs that balance cost and convenience.

Online degrees in these fields allow greater flexibility, help control educational expenses, and provide varied career opportunities in the evolving healthcare landscape.

Best Scientists Citing Massimo Terzolo

Trending Scientists

Recently Published Articles